Inventor profile of:

Roberto A. Maldonado

City:

Berkeley, California

Country:

United States

Published Applications:

14

Last publication date:

2025-06-05

Top Assignees for applications by Roberto A. Maldonado

The entities that hold a legal rights for patent applications filed by inventor Maldonado Roberto A.:

Recent patent applications by Maldonado Roberto A.

Roberto A. Maldonado from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-05
US20250177360A1
Human necessities

METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE

#2 | 2024-08-08
US20240261396A1
Human necessities

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

#3 | 2024-05-16
US20240156955A1
Human necessities

TOLEROGENIC SYNTHETIC NANOCARRIERS

#4 | 2023-10-12
US20230321225A1
Human necessities

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS

#5 | 2023-10-12
US20230321224A1
Human necessities

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES

#6 | 2023-10-05
US20230310593A1
Human necessities

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

#7 | 2023-02-02
US20230032226A1
Human necessities

METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY

#8 | 2022-11-10
US20220354947A1
Human necessities

METHODS FOR PROVIDING POLYMERIC SYNTHETIC NANOCARRIERS FOR GENERATING ANTIGEN-SPECIFIC TOLERANCE IMMUNE RESPONSES

#9 | 2020-11-19
US20200360350A1
Human necessities

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE OR PREVENT ANAPHYLAXIS IN RESPONSE TO A NON-ALLERGENIC ANTIGEN

#10 | 2020-04-16
US20200113874A1
Human necessities

METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE

#11 | 2020-04-02
US20200101155A1
Human necessities

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS

#12 | 2020-04-02
US20200101154A1
Human necessities

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS

#13 | 2020-03-12
US20200078341A1
Human necessities

Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity

#14 | 2020-03-05
US20200069660A1
Human necessities

METHODS COMPRISING DOSING COMBINATIONS FOR REDUCING UNDESIRED HUMORAL IMMUNE RESPONSES

InventorID:

2660395 ⎘